Research Overview CJC-1295 + Ipamorelin Blend is a physical research blend of Modified GRF(1-29), commonly marketed as CJC-1295 No DAC, and Ipamorelin
Excessive ROS production beyond self-regulation processes leads to irreversible damage to cellular function or death (Rotariu et al., 2022)
They disrupt fundamental cellular processes, including energy production, insulin signaling, glucose metabolism, and mitochondrial function, at times contributing to cognitive decline, fatigue, reduced ability to fight infections, and increased chronic disease risk
MHRA approves GLP-1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults
Multiple human studies have confirmed zero impact on fasting glucose, insulin, HbA1c, or IGF-1 levels (Thompson et al., 2004)